Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UBS Maintains Buy on Aptiv, Lowers Price Target to $99

Author: Benzinga Newsdesk | July 10, 2024 09:28am
UBS analyst Joseph Spak maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $107 to $99.

Posted In: APTV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist